Is Ascentage Pharma Group International (AAPG) a Buy, Sell, or Hold?
NASDAQ : AAPG
Ascentage Pharma Group International — Insider Trades
$18.29 USD
-$1.04 (-5.36%)
- Volume
- 4.5K
- Average Volume
- 11.3K
- Market Capitalization
- $1.7B
- P/E Ratio
- -8.94
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $48.45
- Year Low
- $16.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.79
Insider Activity Summary (Last 12 Months)
Insiders Buying
21
Insiders Selling
2
Amount of Insider Selling
$188.32K
AAPG Insider Buying/Selling by Quarter
AAPG Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Miyara Faical | 2026-06-25 | 0 | 2026-06-29 | ||
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 8.12 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 8.12 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Misra Veet | officer: Chief Financial Officer | 2026-04-20 | A-Award | 0 | 2026-04-21 |
| Misra Veet | 2026-03-18 | 0 | 2026-04-21 | ||
| Cao Jin | officer: Chief Accounting Officer | 2026-03-18 | 0 | 2026-04-20 | |
| Cao Jin | officer: Chief Accounting Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 8.14 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 8.14 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-23 | |
| Yu Debra | director | 2026-03-18 | 0 | 2026-03-23 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-23 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-23 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-23 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 8.14 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 0 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 8.14 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 0 | 2026-03-23 | |
| Bozilenko Marina | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-19 | |
| Bozilenko Marina | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Bozilenko Marina | director | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 8.14 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-19 | |
| Lu Simon Dazhong | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-19 | |
| Yu Debra | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Yu Debra | director | 2026-03-18 | 0 | 2026-03-19 |